WKN: | A3EU6F |
ISIN: | DK0062498333 |
Land: | Dänemark |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Gesundheit |
Weshalb die Novo Nordisk-Aktie
ein AAA-Rating hat,
erfahren Sie im Performance-Check
vom 22. Juli 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2010 | 4,48 | 8,50 | 89,73% |
2 | 1997 | 0,67 | 1,21 | 80,60% |
3 | 2021 | 29,03 | 49,40 | 70,17% |
4 | 2000 | 1,22 | 1,89 | 54,92% |
5 | 2015 | 17,72 | 26,93 | 51,98% |
6 | 1991 | 0,21 | 0,31 | 47,62% |
7 | 2023 | 63,50 | 93,60 | 47,40% |
8 | 1996 | 0,46 | 0,67 | 45,65% |
9 | 2007 | 3,17 | 4,43 | 39,75% |
10 | 2012 | 8,94 | 12,29 | 37,47% |
11 | 2006 | 2,38 | 3,17 | 33,19% |
12 | 2014 | 13,32 | 17,72 | 33,03% |
13 | 2019 | 19,71 | 26,13 | 32,57% |
14 | 1995 | 0,35 | 0,46 | 31,43% |
15 | 2017 | 17,11 | 22,43 | 31,09% |
16 | 2022 | 49,40 | 63,50 | 28,54% |
17 | 2004 | 1,61 | 2,00 | 24,22% |
18 | 2009 | 3,71 | 4,48 | 20,75% |
19 | 2001 | 1,89 | 2,26 | 19,58% |
20 | 2005 | 2,00 | 2,38 | 19,00% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2002 | 2,26 | 1,40 | -38,05% |
2 | 2016 | 26,93 | 17,11 | -36,46% |
3 | 2025 | 83,73 | 55,75 | -33,42% |
4 | 2008 | 4,43 | 3,71 | -16,25% |
5 | 1994 | 0,40 | 0,35 | -12,50% |
6 | 2018 | 22,43 | 19,71 | -12,13% |
7 | 1998 | 1,21 | 1,07 | -11,57% |
8 | 2024 | 93,60 | 83,73 | -10,54% |
9 | 2011 | 8,50 | 8,94 | 5,18% |
10 | 2013 | 12,29 | 13,32 | 8,38% |
11 | 1990 | 0,19 | 0,21 | 10,53% |
12 | 2020 | 26,13 | 29,03 | 11,10% |
13 | 1992 | 0,31 | 0,35 | 12,90% |
14 | 1999 | 1,07 | 1,22 | 14,02% |
15 | 1993 | 0,35 | 0,40 | 14,29% |
16 | 2003 | 1,40 | 1,61 | 15,00% |
17 | 1989 | 0,16 | 0,19 | 18,75% |
18 | 2005 | 2,00 | 2,38 | 19,00% |
19 | 2001 | 1,89 | 2,26 | 19,58% |
20 | 2009 | 3,71 | 4,48 | 20,75% |